Financial & competing interests disclosure
NPS Pharmaceuticals and Takeda funded the research regarding teduglutide referenced in this review. The author has served as a consultant for NPS Pharmaceuticals and Takeda. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.